학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 64건 | 목록
1~20
Academic Journal
Wen, Patrick Y ; Stein, Alexander ; van den Bent, Martin ; De Greve, Jacques ; Wick, Antje ; de Vos, Filip Y F L ; von Bubnoff, Nikolas ; van Linde, Myra E ; Lai, Albert ; Prager, Gerald W ; Campone, Mario ; Fasolo, Angelica ; Lopez-Martin, Jose A ; Kim, Tae Min ; Mason, Warren P ; Hofheinz, Ralf-Dieter ; Blay, Jean-Yves ; Cho, Daniel C ; Gazzah, Anas ; Pouessel, Damien ; Yachnin, Jeffrey ; Boran, Aislyn ; Burgess, Paul ; Ilankumaran, Palanichamy ; Gasal, Eduard ; Subbiah, Vivek
In The Lancet Oncology January 2022 23(1):53-64
Academic Journal
Atkins, Michael B ; Plimack, Elizabeth R ; Puzanov, Igor ; Fishman, Mayer N ; McDermott, David F ; Cho, Daniel C ; Vaishampayan, Ulka ; George, Saby ; Olencki, Thomas E ; Tarazi, Jamal C ; Rosbrook, Brad ; Fernandez, Kathrine C ; Lechuga, Mariajose ; Choueiri, Toni K
In The Lancet Oncology March 2018 19(3):405-415
Academic Journal
Diab, Adi; Tykodi, Scott S; Daniels, Gregory A; Maio, Michele; Curti, Brendan D; Lewis, Karl D; Jang, Sekwon; Kalinka, Ewa; Puzanov, Igor; Spira, Alexander I; Cho, Daniel C; Guan, Shanhong; Puente, Erika; Nguyen, Tuan; Hoch, Ute; Currie, Sue L; Lin, Wei; Tagliaferri, Mary A; Zalevsky, Jonathan; Sznol, Mario
Academic Journal
McDermott, David F; Lee, Jae-Lyun; Bjarnason, Georg A; Larkin, James M G; Gafanov, Rustem A; Kochenderfer, Mark D; Jensen, Niels Viggo; Donskov, Frede; Malik, Jahangeer; Poprach, Alexandr; Tykodi, Scott S; Alonso-Gordoa, Teresa; Cho, Daniel C; Geertsen, Poul F; Climent Duran, Miguel Angel; DiSimone, Christopher; Silverman, Rachel Kloss; Perini, Rodolfo F; Schloss, Charles; Atkins, Michael B
Academic Journal
Emamekhoo H; University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.; Olsen MR; Oklahoma Cancer Specialists and Research Institute, Tulsa, Oklahoma.; Carthon BC; Department of Hematology and Medical Oncology, Emory University Hospital Midtown, Atlanta, Georgia.; Drakaki A; Division of Hematology/Oncology, Institute of Urologic Oncology, UCLA Health, Los Angeles, California.; Percent IJ; Florida Cancer Specialists, Port Charlotte, Florida.; Molina AM; Weill Cornell Medicine, New York, New York.; Cho DC; Perlmutter Cancer Center at New York University Langone Medical Center, New York, New York.; Bendell JC; Sarah Cannon Research Institute/Tennessee Oncology, Nashville, Tennessee.; Gordan LN; Florida Cancer Specialists North/Sarah Cannon Research Institute, Gainesville, Florida.; Rezazadeh Kalebasty A; Norton Cancer Institute, Louisville, Kentucky.; George DJ; Duke University Medical Center, Durham, North Carolina.; Hutson TE; Texas A&M College of Medicine, Bryan, Texas.; Arrowsmith ER; Sarah Cannon Research Institute/Tennessee Oncology, Chattanooga, Tennessee.; Zhang J; Bristol Myers Squibb, Princeton, New Jersey.; Zoco J; Syneos Health, Braine l'Alleud, Belgium.; Johansen JL; Bristol Myers Squibb, Princeton, New Jersey.; Leung DK; Bristol Myers Squibb, Princeton, New Jersey.; Tykodi SS; University of Washington and Fred Hutchinson Cancer Research Center, Seattle, Washington.
Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE
Munster P; Iannotti N; Cho DC; Kirkwood JM; Villaruz LC; Gibney GT; Hodi FS; Mettu NB; Jones M; Bowman J; Smith M; Lakshminarayanan M; O'Day S
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun Subsets: PubMed not MEDLINE; MEDLINE
Academic Journal
Munster P; Department of Medicine, Division of Hematology/Oncology, UCSF, San Francisco, California.; Iannotti N; Hematology-Oncology Associates of Treasure Coast, Port St Lucie, Florida.; Cho DC; NYU Laura & Isaac Perlmutter Cancer Center at NYU Langone, New York City, New York City.; Kirkwood JM; UPMC Hillman Cancer Center Melanoma and Skin Cancer Program, Pittsburgh, Pennsylvania.; Villaruz LC; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.; Gibney GT; Georgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia.; Hodi FS; Dana-Farber Cancer Institute, Boston, Massachusetts.; Mettu NB; Duke Cancer Institute, Durham, North Carolina.; Jones M; Incyte Corporation, Wilmington, Delaware.; Bowman J; Incyte Corporation, Wilmington, Delaware.; Smith M; Incyte Corporation, Wilmington, Delaware.; Lakshminarayanan M; Incyte Corporation, Wilmington, Delaware.; O'Day S; John Wayne Cancer Institute of Providence, Saint John's Health Center, Santa Monica, California.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun Subsets: MEDLINE
Academic Journal
Shapiro GI; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. geoffrey_shapiro@dfci.harvard.edu.; LoRusso P; Yale Cancer Center, New Haven, CT, USA.; Cho DC; Perlmutter Cancer Center at NYU Langone Medical Center, New York, NY, USA.; Musib L; Genentech, Inc., South San Francisco, CA, USA.; Yan Y; Genentech, Inc., South San Francisco, CA, USA.; Wongchenko M; Genentech, Inc., South San Francisco, CA, USA.; Chang I; Genentech, Inc., South San Francisco, CA, USA.; Celltrion, Inc., Incheon, South Korea.; Patel P; Genentech, Inc., South San Francisco, CA, USA.; Chan IT; Genentech, Inc., South San Francisco, CA, USA.; Sanabria-Bohorquez S; Genentech, Inc., South San Francisco, CA, USA.; Meng RD; Genentech, Inc., South San Francisco, CA, USA.; Bendell JC; Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN, USA.
Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE
Academic Journal
Subbiah V; Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. vsubbiah@mdanderson.org.; Kreitman RJ; Laboratory of Molecular Biology, National Institutes of Health, Bethesda, MD, USA.; Wainberg ZA; Department of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.; Gazzah A; Drug Development Department (DITEP), Gustave Roussy Cancer Institute, Villejuif, France.; Lassen U; Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Stein A; Department of Internal Medicine II (Oncology Center), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Dietrich S; University of Heidelberg, Heidelberg, Germany.; de Jonge MJA; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Blay JY; Center Leon Berard & University Claude Bernard Lyon I, Lyon, France.; Italiano A; Early Phase Trials and Sarcoma Units, Institut Bergonié, Bordeaux, France; Faculty of Medicine, University of Bordeaux, Bordeaux, France.; Yonemori K; National Cancer Center Hospital, Tokyo, Japan.; Cho DC; New York Medical College, Valhalla, NY, USA.; de Vos FYFL; Department of Medical Oncology, University Medical Center Utrecht, University Utrecht, Utrecht, The Netherlands.; Moreau P; Department of Hematology, CHU de Nantes, Nantes, France.; Fernandez EE; Department of Medical Oncology, Vall d'Hebron University Hospital (HUVH), Vall d'Hebron Institute of Oncology (VHIO), IOB-Quiron, UVic-UCC, Barcelona, Spain.; Schellens JHM; Netherlands Cancer Institute, Amsterdam, The Netherlands.; Zielinski CC; Medical University of Vienna, Vienna, Austria.; Redhu S; Global Program Biostatistics, Novartis Oncology, Cambridge, MA, USA.; Boran A; Global Drug Development, Oncology Development Unit, Novartis Services, Inc., East Hanover, NJ, USA.; Passos VQ; Global Drug Development, Oncology Development Unit, Novartis Services, Inc., East Hanover, NJ, USA.; Ilankumaran P; Global Drug Development, Oncology Development Unit, Novartis Services, Inc., East Hanover, NJ, USA.; Bang YJ; Seoul National University College of Medicine, Seoul, Republic of Korea.
Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE
Academic Journal
Postel-Vinay S; Département d'Innovation Thérapeutique et d'Essais Précoces (DITEP), Gustave Roussy, Université Paris Saclay, Villejuif, France sophie.postel-vinay@gustaveroussy.fr.; Lam VK; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Ros W; Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Bauer TM; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Hansen AR; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Cho DC; New York Medical College, Valhalla, New York, USA.; Stephen Hodi F; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Schellens JHM; Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Litton JK; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Aspeslagh S; Département d'Innovation Thérapeutique et d'Essais Précoces (DITEP), Gustave Roussy, Université Paris Saclay, Villejuif, France.; Autio KA; Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Opdam FL; Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; McKean M; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Somaiah N; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Champiat S; Département d'Innovation Thérapeutique et d'Essais Précoces (DITEP), Gustave Roussy, Université Paris Saclay, Villejuif, France.; Altan M; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Spreafico A; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Rahma O; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Paul EM; GlaxoSmithKline, Research Triangle Park, North Carolina, USA.; Ahlers CM; Replimune Group Inc, Woburn, Massachusetts, USA.; Zhou H; GlaxoSmithKline, Collegeville, Pennsylvania, USA.; Struemper H; GlaxoSmithKline, Research Triangle Park, North Carolina, USA.; Gorman SA; GlaxoSmithKline, Collegeville, Pennsylvania, USA.; Watmuff M; GlaxoSmithKline, Collegeville, Pennsylvania, USA.; Yablonski KM; GlaxoSmithKline, Collegeville, Pennsylvania, USA.; Yanamandra N; GlaxoSmithKline, Collegeville, Pennsylvania, USA.; Chisamore MJ; Merck & Co Inc, Kenilworth, New Jersey, USA.; Schmidt EV; Merck & Co Inc, Kenilworth, New Jersey, USA.; Hoos A; GlaxoSmithKline, Collegeville, Pennsylvania, USA.; Marabelle A; Département d'Innovation Thérapeutique et d'Essais Précoces (DITEP), Gustave Roussy, Université Paris Saclay, Villejuif, France.; Weber JS; Perlmutter Cancer Center, NYU Langone Health, New York, New York, USA.; Heymach JV; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Academic Journal
J Cell Mol Med
Academic Journal
Siefker-Radtke AO; University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: asiefker@mdanderson.org.; Cho DC; New York Medical College, Westchester Medical Center, Valhalla, NY, USA.; Diab A; University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Sznol M; Yale Cancer Center, New Haven, CT, USA.; Bilen MA; Winship Cancer Institute of Emory University, Atlanta, GA, USA.; Balar AV; New York Medical College, Westchester Medical Center, Valhalla, NY, USA.; Grignani G; Division of Medical Oncology, Candiolo Cancer Institute FPO-IRCCS, Candiolo, Turin, Italy.; Puente E; Nektar Therapeutics, San Francisco, CA, USA.; Tang L; Nektar Therapeutics, San Francisco, CA, USA.; Chien D; Nektar Therapeutics, San Francisco, CA, USA.; Hoch U; Nektar Therapeutics, San Francisco, CA, USA.; Choudhury A; Nektar Therapeutics, San Francisco, CA, USA.; Yu D; Nektar Therapeutics, San Francisco, CA, USA.; Currie SL; Nektar Therapeutics, San Francisco, CA, USA.; Tagliaferri MA; Nektar Therapeutics, San Francisco, CA, USA.; Zalevsky J; Nektar Therapeutics, San Francisco, CA, USA.; Hurwitz ME; Yale Cancer Center, New Haven, CT, USA.; Tannir NM; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE
Academic Journal
Davis EJ; Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Martin-Liberal J; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Kristeleit R; Research Department of Oncology, University College London, London, UK.; Cho DC; Perlmutter Cancer Center, NYU Langone Health, NYU Grossman School of Medicine, New York, New York, USA.; Blagden SP; Department of Oncology, University of Oxford, Oxford, UK.; Berthold D; Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.; Cardin DB; Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Vieito M; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Miller RE; University College London Hospital, London, UK.; Hari Dass P; Early Phase Clinical Trials Unit, Churchill Hospital, University of Oxford, Oxford, UK.; Orcurto A; Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.; Spencer K; Rutgers University, New Brunswick, New Jersey, USA.; Janik JE; Incyte Corporation, Wilmington, Delaware, USA.; Clark J; Incyte Corporation, Wilmington, Delaware, USA.; Condamine T; Incyte Corporation, Wilmington, Delaware, USA.; Pulini J; Incyte Corporation, Wilmington, Delaware, USA.; Chen X; Incyte Corporation, Wilmington, Delaware, USA.; Mehnert JM; Rutgers University, New Brunswick, New Jersey, USA janice.mehnert@nyulangone.org.
Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Academic Journal
Sanborn RE; Providence Cancer Institute, Earle A. Chiles Research Institute, Portland, Oregon, USA Rachel.sanborn@providence.org.; Pishvaian MJ; Department of Oncology, Georgetown-Lombardi Comprehensive Cancer Center, Washington, District of Columbia, USA.; Callahan MK; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Weise A; Karmanos Cancer Institute, Detroit, Michigan, USA.; Sikic BI; Clinical and Translational Research Unit, Stanford Cancer Institute, Stanford, California, USA.; Rahma O; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA.; Cho DC; Perlmutter Cancer Center, NYU Langone Medical Center, New York, New York, USA.; Rizvi NA; Division of Hematology/Oncology, Columbia University Medical Center, New York, New York, USA.; Sznol M; Smilow Cancer Hospital, New Haven, Connecticut, USA.; Lutzky J; Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida, USA.; Bauman JE; University of Arizona Cancer Center, Tuscon, Arizona, USA.; Bitting RL; Wake Forest Baptist Health, Winston-Salem, North Carolina, USA.; Starodub A; Parkview Research Center, Fort Wayne, Indiana, USA.; Jimeno A; Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Reardon DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Kaley T; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Iwamoto F; Department of Neurology, Columbia Presbyterian Medical Center, New York, New York, USA.; Baehring JM; Department of Neurosurgery, Yale New Haven Health Smilow Cancer Hospital, New Haven, Connecticut, USA.; Subramaniam DS; Department of Oncology, Georgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia, USA.; Aragon-Ching JB; Inova Schar Cancer Institute, Fairfax, Virginia, USA.; Hawthorne TR; Celldex Therapeutics Inc New Haven, New Haven, Connecticut, USA.; Rawls T; Celldex Therapeutics Inc, Hampton, New Jersey, USA.; Yellin M; Celldex Therapeutics Inc, Hampton, New Jersey, USA.; Keler T; R & D, Celldex Therapeutics Inc, Hampton, New Jersey, USA.
Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Academic Journal
Tannir NM; University of Texas MD Anderson Cancer Center, Houston, Texas, USA ntannir@mdanderson.org.; Cho DC; New York Medical College, Westchester Medical Center, Valhalla, New York, USA.; Diab A; University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Sznol M; Yale Cancer Center, New Haven, Connecticut, USA.; Bilen MA; Winship Cancer Institute of Emory University, Atlanta, Georgia, USA.; Balar AV; New York Medical College, Westchester Medical Center, Valhalla, New York, USA.; Grignani G; Division of Medical Oncology, Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Turin, Italy.; Puente E; Nektar Therapeutics, San Francisco, California, USA.; Tang L; Nektar Therapeutics, San Francisco, California, USA.; Chien D; Nektar Therapeutics, San Francisco, California, USA.; Hoch U; Nektar Therapeutics, San Francisco, California, USA.; Choudhury A; Nektar Therapeutics, San Francisco, California, USA.; Yu D; Nektar Therapeutics, San Francisco, California, USA.; Currie SL; Nektar Therapeutics, San Francisco, California, USA.; Tagliaferri MA; Nektar Therapeutics, San Francisco, California, USA.; Zalevsky J; Nektar Therapeutics, San Francisco, California, USA.; Siefker-Radtke AO; University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Hurwitz ME; Yale Cancer Center, New Haven, Connecticut, USA.
Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Academic Journal
Sanborn RE; Department of Medical Oncology, Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA Rachel.Sanborn@providence.org.; Hamid O; Department of Medical Oncology, The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate, Los Angeles, California, USA.; de Vries EG; Department of Medical Oncology, Universitair Medisch Centrum Groningen, University of Groningen, Groningen, Netherlands.; Ott PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Garcia-Corbacho J; Department of Medical Oncology, Hospital Clinic Barcelona/IDIBAPS, Barcelona, Spain.; Boni V; Department of Medical Oncology, START Madrid-CIOCC, Hospital Universitario HM Sanchinarro, Madrid, Spain.; Bendell J; Sarah Cannon Research Institute/Tennessee Oncology, Nashville, Tennessee, USA.; Autio KA; Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Cho DC; Department of Medicine, Perlmutter Cancer Center at NYU Langone Medical Center, New York, New York, USA.; Plummer R; Department of Medical Oncology, Northern Centre for Cancer Care, Newcastle Hospitals NHS Trust and Newcastle University, Newcastle upon Tyne, UK.; Stroh M; CytomX Therapeutics Inc, South San Francisco, California, USA.; Lu L; CytomX Therapeutics Inc, South San Francisco, California, USA.; Thistlethwaite F; Department of Medical Oncology, The Christie Hospital NHS Foundation Trust and University of Manchester, Manchester, UK.
Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Academic Journal
Atkins MB; Georgetown-Lombardi Comprehensive Cancer Center, 3800 Reservoir Road, NW, Washington DC, 20057, USA. Electronic address: mba41@georgetown.edu.; Plimack ER; Fox Chase Cancer Center, 333 Cottman Ave, Philadelphia, PA, 19111, USA. Electronic address: elizabeth.plimack@fccc.edu.; Puzanov I; Vanderbilt University Medical Center, 1211 Medical Center Dr, Nashville, TN, 7232, USA; Roswell Park Comprehensive Cancer Center, 665 Elm St, Buffalo, NY, 14203, USA. Electronic address: Igor.Puzanov@roswellpark.org.; Fishman MN; Moffitt Cancer Center, 12902 USF Magnolia Drive, Tampa, FL, 33612, USA. Electronic address: fishman@usf.edu.; McDermott DF; Beth Israel Deaconess Medical Center, 330 Brookline Ave, Boston, MA, 02215, USA. Electronic address: dmcdermo@bidmc.harvard.edu.; Cho DC; Perlmutter Cancer Center at NYU Langone Medical Center, 240 E 38th St 19th floor, New York, NY, 10016, USA. Electronic address: daniel.cho@nyumc.org.; Vaishampayan U; Karmanos Cancer Institute, Wayne State University, 4100 John R St, Detroit, MI, 48201, USA. Electronic address: vaishamu@med.umich.edu.; George S; Roswell Park Comprehensive Cancer Center, 665 Elm St, Buffalo, NY, 14203, USA. Electronic address: Saby.George@roswellpark.org.; Tarazi JC; Pfizer Global Product Development-Oncology, 10777 Science Center Dr, San Diego, CA, 92121, USA. Electronic address: jamal.tarazi@pfizer.com.; Duggan W; Pfizer Global Product Development-Oncology, 280 Shennecossett Rd, Groton, CT, 06340, USA. Electronic address: william.t.duggan@pfizer.com.; Perini R; Merck & Co, Inc, 2000 Galloping Hill Rd, Kenilworth, NJ, 07033, USA. Electronic address: rodolfo.perini@merck.com.; Thakur M; Pfizer, Discovery Park, Ramsgate Rd, Sandwich, CT13 9ND, UK. Electronic address: mahgull.thakur@pfizer.com.; Fernandez KC; Pfizer Global Product Development-Oncology, 1 Portland St, Cambridge, MA, 02139, USA. Electronic address: kathrine.fernandez@pfizer.com.; Choueiri TK; Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA. Electronic address: Toni_Choueiri@dfci.harvard.edu.
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Academic Journal
Toth AT; Senior Clinical Research Coordinator, Phase I Drug Development Program, The Laura and Isaac Perlmutter Cancer Center at NYU Langone Medical Center, New York, NY, USA.; Cho DC; Director, Phase I Drug Development Program, The Laura and Isaac Perlmutter Cancer Center at NYU Langone Medical Center, New York, NY, USA.
Publisher: Codon Publications Country of Publication: Australia NLM ID: 101695919 Publication Model: eCollection Cited Medium: Internet ISSN: 2203-5826 (Electronic) Linking ISSN: 22035826 NLM ISO Abbreviation: J Kidney Cancer VHL Subsets: PubMed not MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Cho, Daniel C
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어